GAITHERSBURG, Maryland (Reuters) - A U.S. panel dealt a blow to Roche Holding AG's multibillion-dollar cancer drug Avastin on Tuesday, urging U.S. officials to revoke the medicine's approval for ...

LOS ANGELES (Reuters) - Colorectal cancer patients who continued treatment with Roche Holding AG's Avastin even after their cancer worsened lived longer than those who went off the drug, according to ...

Medicare said this week it will pay for two cancer treatments with hefty price tags -- and lingering questions: Avastin, the controversial drug shot down by an Food and Drug Administration panel on ...

The DUO-O trial showed significant improvement in progression-free survival with Imfinzi, Avastin, and Lynparza, but no significant overall survival benefit. The study was a double-blind, multicenter ...

The FDA is warning health care professional about a counterfeit version of Avastin 400mg/16mL (Bevacizumab, Genentech), which may have been purchased and used by some medical practices in the U.S. The ...